ISPE Podcast: Shaping the Future of Pharma

Scott Billman, Senior Vice President, Global Engineering, Technology, and Facilities at Solventum and Immediate Past Chair of the ISPE International Board of Directors, joins the podcast to share more about the upcoming ISPE Annual Meeting and Expo. Explore the featured topics, trends, and pharmaceutical innovations, as well as opportunities for networking and career advancement that you can expec...

On this episode, Gunter Baumgartner, SVP Head of Global Engineering at Takeda Pharmaceuticals International AG, and Executive Chair of 2025 ISPE Annual Meeting and Expo, joins the podcast to discuss the upcoming conference and the topics, speakers, and key highlights of what you can expect from the educational content and agenda.

On this episode, Gunter Baumgartner, SVP Head of Global Engineering at Takeda Pharmaceuticals International AG, and Executive Chair of 2025 ISPE Annual Meeting and Expo, joins the podcast to discuss the upcoming conference and the topics, speakers, and key highlights of what you can expect from the educational content and agenda.

In part two of our series on the future of ATMPs, Marco Flori, Global Account Manager at Staubli Robotic UK, and Dan Strange, CTO and Co-founder of Cellular Origins, join the podcast to share more about the potential and benefits of automation and robotics in the production of cellular and gene therapies.  

In part two of our series on the future of ATMPs, Marco Flori, Global Account Manager at Staubli Robotic UK, and Dan Strange, CTO and Co-founder of Cellular Origins, join the podcast to share more about the potential and benefits of automation and robotics in the production of cellular and gene therapies.  

In part one of our two-part series on the future of ATMPs, David Phasey, Business Development Director at 3P Innovation, joins the podcast to discuss the drivers of the high cost-of-goods (COGs) for ATMPs and how automation can help reduce these COGs in the future.  

In part one of our two-part series on the future of ATMPs, David Phasey, Business Development Director at 3P Innovation, joins the podcast to discuss the drivers of the high cost-of-goods (COGs) for ATMPs and how automation can help reduce these COGs in the future.  

This episode, Ben Stevens, Director of CMC Policy and Advocacy with GSK, and Eric Staib, Vice President of Corporate Quality with Syneos, join the podcast to share more about the current state of AI in the pharmaceutical industry, key AI-related challenges and opportunities facing the industry, and the work they’re doing on ISPE’s recently established Artificial Intelligence Community of Practice...

This episode, Ben Stevens, Director of CMC Policy and Advocacy with GSK, and Eric Staib, Vice President of Corporate Quality with Syneos, join the podcast to share more about the current state of AI in the pharmaceutical industry, key AI-related challenges and opportunities facing the industry, and the work they’re doing on ISPE’s recently established Artificial Intelligence Community of Practice...

This episode, Takeda’s Senior Vice President, Head of Global Quality Compliance and Systems, Magaly Aham, joins the podcast to discuss how AI can enable sustainable quality transformation. She’ll touch on Takeda’s unique approach to leveraging AI, share a few key case study examples, and elaborate on how she envisions their work will help to move the industry forward.

This episode, Takeda’s Senior Vice President, Head of Global Quality Compliance and Systems, Magaly Aham, joins the podcast to discuss how AI can enable sustainable quality transformation. She’ll touch on Takeda’s unique approach to leveraging AI, share a few key case study examples, and elaborate on how she envisions their work will help to move the industry forward.

Mike Martin, President and CEO of ISPE, joins ISPE’s podcast host Robert Chew for this first episode to discuss the current pharmaceutical landscape, how the industry is responding to new challenges and opportunities, where he sees the industry going in the next five years, and more.